IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation
Cells · 2023
DOI: 10.3390/cells12111493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Young-Ae Choi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cell & Matrix Research Institute, Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, IgE, Anaphylaxis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
(1)
Background
This study aims to elucidate a novel non-transcriptional action of IRF3 in addition to its role as a transcription factor in mast cell activation and associated allergic inflammation; (2)
Methods
For in vitro experiments, mouse bone-marrow-derived mast cells (mBMMCs) and a rat basophilic leukemia cell line (RBL-2H3) were used for investigating the underlying mechanism of IRF3 in mast-cell-mediated allergic inflammation. For in vivo experiments, wild-type and Irf3 knockout mice were used for evaluating IgE-mediated local and systemic anaphylaxis; (3)
Results
Passive cutaneous anaphylaxis (PCA)-induced tissues showed highly increased IRF3 activity. In addition, the activation of IRF3 was observed in DNP-HSA-treated mast cells. Phosphorylated IRF3 by DNP-HSA was spatially co-localized with tryptase according to the mast cell activation process, and FcεRI-mediated signaling pathways directly regulated that activity. The alteration of IRF3 affected the production of granule contents in the mast cells and the anaphylaxis responses, including PCA- and ovalbumin-induced active systemic anaphylaxis. Furthermore, IRF3 influenced the post-translational processing of histidine decarboxylase (HDC), which is required for granule maturation; and (4)
Conclusion
Through this study, we demonstrated the novel function of IRF3 as an important factor inducing mast cell activation and as an upstream molecule for HDC activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell & Matrix Research Institute, Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Immunoregulatory Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 56212, Republic of Korea.
- Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
- Department of Physiology, School of Medicine, Gachon University, Incheon 21999, Republic of Korea.
ORCID-Profile: Young-Ae Choi, Taeg Kyu Kwon, Dongwoo Khang
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, Y. A., Dhakal, H., Lee, S., Kim, N., Lee, B., Kwon, T. K., Khang, D., & Kim, S. H. (2023). IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation. Cells. https://doi.org/10.3390/cells12111493
Vancouver
Choi YA, Dhakal H, Lee S, Kim N, Lee B, Kwon TK, et al. IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation. Cells. 2023. doi:10.3390/cells12111493
BibTeX
@article{Choi2023,
author = {Choi, Young-Ae and Dhakal, Hima and Lee, Soyoung and Kim, Namkyung and Lee, Byungheon and Kwon, Taeg Kyu and Khang, Dongwoo and Kim, Sang-Hyun},
title = {IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12111493}
}
EUVIMED